These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37402066)

  • 1. Ribosomal S6 kinase 4 (RSK4) tumor suppressor gene promoter methylation status in ovarian cancer.
    Arechavaleta-Velasco F; Dominguez-Lopez P; Acosta-Jimenez E; Diaz-Cueto L
    Mol Biol Rep; 2023 Aug; 50(8):6863-6870. PubMed ID: 37402066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribosomal S6 kinase 4 (RSK4) expression in ovarian tumors and its regulation by antineoplastic drugs in ovarian cancer cell lines.
    Arechavaleta-Velasco F; Zeferino-Toquero M; Estrada-Moscoso I; Imani-Razavi FS; Olivares A; Perez-Juarez CE; Diaz-Cueto L
    Med Oncol; 2016 Feb; 33(2):11. PubMed ID: 26732474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation of the RSK4 promoter associated with BRAF V600E promotes papillary thyroid carcinoma.
    Yin Y; Che K; Hu J; Hua H; Dong A; Wang J; Yu J; Zhang Q; Zhao S; Zhao Y; Wang P; Wang F; Wang Y; Chi J; Sun W
    Int J Oncol; 2020 May; 56(5):1284-1293. PubMed ID: 32319586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 (RSK4) in endometrial cancers.
    Dewdney SB; Rimel BJ; Thaker PH; Thompson DM; Schmidt A; Huettner P; Mutch DG; Gao F; Goodfellow PJ
    Clin Cancer Res; 2011 Apr; 17(8):2120-9. PubMed ID: 21372219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent epigenetic inactivation of RSK4 by promoter methylation in cancerous and non-cancerous tissues of breast cancer.
    Li Q; Jiang Y; Wei W; Ji Y; Gao H; Liu J
    Med Oncol; 2014 Jan; 31(1):793. PubMed ID: 24338215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RSK4 inhibits breast cancer cell proliferation and invasion in vitro, and is correlated with estrogen receptor upregulation in breast cancer.
    Huo H; Ye X; Yang H; Li Q; Jiang Y
    Oncol Rep; 2019 Dec; 42(6):2777-2787. PubMed ID: 31545499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
    Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
    Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells.
    Jacob F; Hitchins MP; Fedier A; Brennan K; Nixdorf S; Hacker NF; Ward R; Heinzelmann-Schwarz VA
    BMC Mol Biol; 2014 Oct; 15():24. PubMed ID: 25294702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
    Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
    Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic anatomy and tumor biology of the RPS6KA6 gene that encodes the p90 ribosomal S6 kinase-4.
    Sun Y; Cao S; Yang M; Wu S; Wang Z; Lin X; Song X; Liao DJ
    Oncogene; 2013 Apr; 32(14):1794-810. PubMed ID: 22614021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway.
    Wang Z; Li M; Lu S; Zhang Y; Wang H
    Cancer Biol Ther; 2006 Mar; 5(3):256-60. PubMed ID: 16418574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells.
    Thakur A; Sun Y; Bollig A; Wu J; Biliran H; Banerjee S; Sarkar FH; Liao DJ
    Clin Cancer Res; 2008 Jul; 14(14):4427-36. PubMed ID: 18628456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation of RASSF2A in tumors and plasma of patients with epithelial ovarian cancer.
    Wu Y; Zhang X; Lin L; Ma XP; Ma YC; Liu PS
    Asian Pac J Cancer Prev; 2014; 15(3):1171-6. PubMed ID: 24606436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer.
    Sheng X; Li J; Yang L; Chen Z; Zhao Q; Tan L; Zhou Y; Li J
    Oncol Rep; 2014 Jul; 32(1):277-85. PubMed ID: 24859196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RSK4 knockdown promotes proliferation, migration and metastasis of human breast adenocarcinoma cells.
    Zhu J; Li QY; Liu JL; Wei W; Yang HW; Tang W
    Oncol Rep; 2015 Dec; 34(6):3156-62. PubMed ID: 26397146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter Methylation Down-regulates Osteoprotegerin Expression in Ovarian Carcinoma.
    Kim JY; Kim SH; Kim HS
    Anticancer Res; 2019 May; 39(5):2361-2367. PubMed ID: 31092428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prominent roles of ribosomal S6 kinase 4 (RSK4) in cancer.
    Xu J; Jia Q; Zhang Y; Yuan Y; Xu T; Yu K; Chai J; Wang K; Chen L; Xiao T; Li M
    Pathol Res Pract; 2021 Mar; 219():153374. PubMed ID: 33621918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of replicative and stress-induced senescence by RSK4, which is down-regulated in human tumors.
    López-Vicente L; Armengol G; Pons B; Coch L; Argelaguet E; Lleonart M; Hernández-Losa J; de Torres I; Ramon y Cajal S
    Clin Cancer Res; 2009 Jul; 15(14):4546-53. PubMed ID: 19584160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of RSK4 on biological characteristics of colorectal cancer.
    Ye Q; Wang X; Jin M; Wang M; Hu Y; Yu S; Yang Y; Yang J; Cai J
    World J Surg Oncol; 2018 Dec; 16(1):240. PubMed ID: 30579335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.
    Kikuchi R; Tsuda H; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
    Cancer Res; 2007 Aug; 67(15):7095-105. PubMed ID: 17671176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.